To include your compound in the COVID-19 Resource Center, submit it here.

GSK’s Rappuoli and colleagues propose model for sustainable vaccine development

A perspective article in Science Translational Medicine co-authored by GlaxoSmithKline’s Rino Rappuoli argues that to make global vaccine development sustainable, pharmas should contribute early in the process and

Read the full 289 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers